Literature DB >> 34286498

Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.

M T Lozano-López1, S Gamonal-Limcaoco, N Casado-Espada, L Aguilar, B Vicente-Hernández, L Grau-López, A Álvarez-Navares, C Roncero.   

Abstract

OBJECTIVE: This study's main objective is to carry out a systematic review of the onset of psychotic symptoms after opioid withdrawal. The opiate dependence correlated to psychiatric symptoms has been well described.
MATERIALS AND METHODS: Following the PRISMA methodology. The consecutive search strategy was applied: (morphine OR buprenorphine OR oxycodone OR tramadol OR fentanyl OR remifentanil OR opioids OR heroin OR methadone) AND (Psychosis OR psychotic symptoms OR schizophrenia).
RESULTS: 12 case reports, 3 series of cases, 2 clinical studies, and 2 reviews were found. It seems that the time association is present in all of them; symptoms appear days after the interruption of the opioid. Most of the articles reported are case reports that describe symptoms that appear after the suspension of the opioid substance; in most cases, the reintroduction of the opioid had therapeutic effects and provoked a remission of these symptoms. These preliminary findings indicate that opiates could have an antipsychotic effect; however, the literature is scarce. It is critical to consider, if needed, in opioid-dependent patients who start with psychosis after the opioid withdrawal the possible replacement or reintroduction of opioids to prevent further deterioration in the patient's mental status.
CONCLUSIONS: This study encompasses a comprehensive description of the literature concerning the possible not well-studied outcome of opioid withdrawal. There are some reports of temporal association between withdrawal and psychotic symptoms that improved after the reintroduction of the opioid; it could be taken into consideration in the clinical practice.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34286498     DOI: 10.26355/eurrev_202107_26248

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report.

Authors:  Yezhe Lin; Alexander D Zhang; Ching-Fang Sun; Justin B White; Ansi Qi; Jessica A Farrell; Robert L Trestman; Rachel K Martin; Anita S Kablinger
Journal:  Psychopharmacol Bull       Date:  2022-06-27

2.  Comparative Study of the Neurotoxic Effects of Pregabalin Versus Tramadol in Rats.

Authors:  Ahmed E Elsukary; Ahmed M N Z Helaly; Amal A El Bakary; Maha E Moustafa; Mohammad A El-Kattan
Journal:  Neurotox Res       Date:  2022-08-17       Impact factor: 3.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.